A combination of a DNA-chimera siRNA against PLK-1 and zoledronic acid suppresses the growth of malignant mesothelioma cells in vitro

Eri Kawata, Eishi Ashihara, Yoko Nakagawa, Takahiro Kiuchi, Mai Ogura, Hisayuku Yao, Kazuki Sakai, Ruriko Tanaka, Rina Nagao, Asumi Yokota, Miki Takeuchi, Shinya Kimura, Hideyo Hirai, Taira Maekawa

研究成果: Contribution to journalArticle

14 引用 (Scopus)

抜粋

Although novel agents effective against malignant mesothelioma (MM) have been developed, the prognosis of patients with MM is still poor. We generated a DNA-chimeric siRNA against polo-like kinase-1 (PLK-1), which was more stable in human serum than the non-chimeric siRNA. The chimeric PLK-1 siRNA inhibited MM cell proliferation through the induction of apoptosis. Next, we investigated the effects of zoledronic acid (ZOL) on MM cells, and found that ZOL also induced apoptosis in MM cells. Furthermore, ZOL augmented the inhibitory effects of the PLK-1 siRNA. In conclusion, combining a PLK-1 siRNA with ZOL treatment is an attractive strategy against MM.

元の言語英語
ページ(範囲)245-253
ページ数9
ジャーナルCancer Letters
294
発行部数2
DOI
出版物ステータス出版済み - 8 1 2010

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

フィンガープリント A combination of a DNA-chimera siRNA against PLK-1 and zoledronic acid suppresses the growth of malignant mesothelioma cells in vitro' の研究トピックを掘り下げます。これらはともに一意のフィンガープリントを構成します。

  • これを引用

    Kawata, E., Ashihara, E., Nakagawa, Y., Kiuchi, T., Ogura, M., Yao, H., Sakai, K., Tanaka, R., Nagao, R., Yokota, A., Takeuchi, M., Kimura, S., Hirai, H., & Maekawa, T. (2010). A combination of a DNA-chimera siRNA against PLK-1 and zoledronic acid suppresses the growth of malignant mesothelioma cells in vitro. Cancer Letters, 294(2), 245-253. https://doi.org/10.1016/j.canlet.2010.02.008